| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |